Relationship of blood pressure and obesity with inflammatory cytokines among African Americans

Therapeutic Advances in Cardiovascular Disease

Volumn 5, Issue 3, 2011, Pages 149-157

  Deloach, Stephanie ^a   Huan, Yonghong ^a   Martinez Cantarin, Maria P ^a   Falkner, Bonita ^a   Keith, Scott W ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

African Americans; Hypertension; Inflammation; Obesity

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUBLIC HEALTH PROBLEM;

ADIPONECTIN; ADOLESCENT; ADULT; AFRICAN AMERICANS; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CYTOKINES; FEMALE; HUMANS; HYPERTENSION; INFLAMMATION MEDIATORS; INSULIN; INTERLEUKIN-6; LINEAR MODELS; MALE; OBESITY; PHILADELPHIA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; YOUNG ADULT;

EID: 79958706883     PISSN: 17539447     EISSN: 17539455     Source Type: Journal    
DOI: 10.1177/1753944711408757     Document Type: Article

References (25)

1. Aronson D. Bartha P. Zinder O. Kerner A. Markiewicz W. Avizohar O. et al (2004) Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome. Int J Obes Relat Metab Disord 28: 674–679.
2. Brooks G.C. Blaha M.J. Blumenthal R.S. (2010) Relation of C-reactive protein to abdominal adiposity. Am J Cardiol 106: 56–61.
3. Calle E.E. Thun M.J. Petrelli J.M. Rodriguez C. Heath C.W. Jr (1999) Body-mass index and mortality in a prospective cohort of US adults. N Engl J Med 341: 1097–1105.
4. Chae C.U. Lee R.T. Rifai N. Ridker P.M. (2001) Blood pressure and inflammation in apparently healthy men. Hypertension 38: 399–403.
5. Davey Smith G. Lawlor D.A. Harbord R. Timpson N. Rumley A. Lowe G.D. et al (2005) Association of C-reactive protein with blood pressure and hypertension: life course confounding and Mendelian randomization tests of causality. Arterioscler Thromb Vasc Biol 25: 1051–1056.
6. Durazo-Arvizu R.A. McGee D.L. Cooper R.S. Liao Y. Luke A. (1998) Mortality and optimal body mass index in a sample of the US population. Am J Epidemiol 147: 739–749.
7. Guzik T.J. Hoch N.E. Brown K.A. McCann L.A. Rahman A. Dikalov S. et al (2007) Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 204: 2449–2460.
8. Hajjar I. Kotchen T.A. (2003) Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA 290: 199–206.
9. Hedley A.A. Ogden C.L. Johnson C.L. Carroll M.D. Curtin L.R. Flegal K.M. (2004) Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. JAMA 291: 2847–2850.
10. Hozawa A. Folsom A.R. Sharrett A.R. Chambless L.E. (2007) Absolute and attributable risks of cardiovascular disease incidence in relation to optimal and borderline risk factors: comparison of African American with white subjects–Atherosclerosis Risk in Communities Study. Arch Intern Med 167: 573–579.
11. Karelis A.D. Faraj M. Bastard J.P. St-Pierre D.H. Brochu M. Prud'homme D. et al (2005) The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 90: 4145–4150.
12. Lakoski S.G. Cushman M. Siscovick D.S. Blumenthal R.S. Palmas W. Burke G. et al (2010) The relationship between inflammation, obesity and risk for hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA). J Hum Hypertens 25: 73–79.
13. Lyon C.J. Law R.E. Hsueh W.A. (2003) Minireview: Adiposity, inflammation, and atherogenesis. Endocrinology 144: 2195–2200.
14. Madhur M.S. Lob H.E. McCann L.A. Iwakura Y. Blinder Y. Guzik T.J. et al (2010) Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension 55: 500–507.
15. Matthews D.R. Hosker J.P. Rudenski A.S. Naylor B.A. Treacher D.F. Turner R.C. (1985) Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412–419.
16. Ridker P.M. Danielson E. Fonseca F.A. Genest J. Gotto A.M. Jr Kastelein J.J. et al (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359: 2195–2207.
17. Ridker P.M. Paynter N.P. Rifai N. Gaziano J.M. Cook N.R. (2008) C-reactive protein and parental history improve global cardiovascular risk prediction: The Reynolds Risk Score for men. Circulation 118: 2243–2251. 4p following 2251.
18. Rocha V.Z. Libby P. (2009) Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol 6: 399–409.
19. Schieffer B. Luchtefeld M. Braun S. Hilfiker A. Hilfiker-Kleiner D. Drexler H. (2000) Role of NAD(P)H oxidase in angiotensin II-induced JAK / STAT signaling and cytokine induction. Circ Res 87: 1195–1201.
20. Shea, J.L., Randell, E.W. and Sun, G. (2010) The prevalence of metabolically healthy obese subjects defined by BMI and dual-energy X-ray absorptiometry. Obesity (Silver Spring) [ePub ahead of print].
21. Vaughan D.E. Lazos S.A. Tong K. (1995) Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin–angiotensin system and thrombosis. J Clin Invest 95: 995–1001.
22. Venugopal S.K. Devaraj S. Yuhanna I. Shaul P. Jialal I. (2002) Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 106: 1439–1441.
23. Wildman R.P. Muntner P. Reynolds K. McGinn A.P. Rajpathak S. Wylie-Rosett J. et al (2008) The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: Prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med 168: 1617–1624.
24. Wu H. Ghosh S. Perrard X.D. Feng L. Garcia G.E. Perrard J.L. et al (2007) T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 115: 1029–1038.
25. Ziccardi P. Nappo F. Giugliano G. Esposito K. Marfella R. Cioffi M. et al (2002) Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 105: 804–809.